New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Scientists uncover new therapeutic target for treating colorectal tumors

Scientists uncover new therapeutic target for treating colorectal tumors

byTokyo University of ScienceA new study by researchers from Japan and China has revealed that inhibiting DCIR, a C-type lectin receptor protein responsible for maintaining homeostasis in the im
World medicine December 16,2023
Scientists uncover new therapeutic target for treating colorectal tumors

Scientists uncover new therapeutic target for treating colorectal tumors

byTokyo University of ScienceA new study by researchers from Japan and China has revealed that inhibiting DCIR, a C-type lectin receptor protein responsible for maintaining homeostasis in the im
World medicine December 16,2023
Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

byAmerican Society of HematologyCredit: CC0 Public DomainYoung people who received doses of tisagenlecleucel, a chimeric antigen receptor T cell (CAR-T) therapy, at the higher end of the FDA-app
World medicine December 16,2023
Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

byAmerican Society of HematologyCredit: CC0 Public DomainYoung people who received doses of tisagenlecleucel, a chimeric antigen receptor T cell (CAR-T) therapy, at the higher end of the FDA-app
World medicine December 16,2023
Updated findings on a new approach to ER-positive/HER2-negative breast cancer

Updated findings on a new approach to ER-positive/HER2-negative breast cancer

byUniversity of California, Los AngelesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 20
World medicine December 16,2023
Updated findings on a new approach to ER-positive/HER2-negative breast cancer

Updated findings on a new approach to ER-positive/HER2-negative breast cancer

byUniversity of California, Los AngelesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 20
World medicine December 16,2023
Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainFor many women who have undergone chemotherapy for breast cancer, cancer-related fatigue (CRF) is a persistent side effect—and one that c
World medicine December 16,2023
Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainFor many women who have undergone chemotherapy for breast cancer, cancer-related fatigue (CRF) is a persistent side effect—and one that c
World medicine December 16,2023
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainScientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their ne
World medicine December 16,2023
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainScientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their ne
World medicine December 16,2023
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

by Impact JournalsRepresentative GPC3 expression by IHC. Credit: Muralidharan et al.A new research paper was published inOncotargeton August 3, 2022, entitled, "Glypican-3 (GPC3) is a
World medicine December 16,2023
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

by Impact JournalsRepresentative GPC3 expression by IHC. Credit: Muralidharan et al.A new research paper was published inOncotargeton August 3, 2022, entitled, "Glypican-3 (GPC3) is a
World medicine December 16,2023
Brain tumor study highlights differences among Hispanics

Brain tumor study highlights differences among Hispanics

by Sarah Avery,Duke UniversityCredit: Unsplash/CC0 Public DomainAlthough typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors
World medicine December 16,2023
Brain tumor study highlights differences among Hispanics

Brain tumor study highlights differences among Hispanics

by Sarah Avery,Duke UniversityCredit: Unsplash/CC0 Public DomainAlthough typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors
World medicine December 16,2023
Enzyme inhibitor slows tumor growth

Enzyme inhibitor slows tumor growth

by Ute Schönfelder, Friedrich-Schiller-Universität JenaDr Christian Kosan is examining proteins after separation in an electrophoresis. His team has discovered a novel therapeutic approach for treatin
World medicine December 16,2023
Enzyme inhibitor slows tumor growth

Enzyme inhibitor slows tumor growth

by Ute Schönfelder, Friedrich-Schiller-Universität JenaDr Christian Kosan is examining proteins after separation in an electrophoresis. His team has discovered a novel therapeutic approach for treatin
World medicine December 16,2023
IASLC early detection and screening committee to report on global obstacles to lung cancer screening

IASLC early detection and screening committee to report on global obstacles to lung cancer screening

by International Association for the Study of Lung CancerMilena Cavic, Institute for Oncology and Radiology of Serbia. Credit: Milena Cavic, Institute for Oncology and Radiology of SerbiaLung cancer s
World medicine December 16,2023
IASLC early detection and screening committee to report on global obstacles to lung cancer screening

IASLC early detection and screening committee to report on global obstacles to lung cancer screening

by International Association for the Study of Lung CancerMilena Cavic, Institute for Oncology and Radiology of Serbia. Credit: Milena Cavic, Institute for Oncology and Radiology of SerbiaLung cancer s
World medicine December 16,2023
Hopes of new curative treatment for children with neuroblastoma

Hopes of new curative treatment for children with neuroblastoma

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainChildren who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival. However, a group including
World medicine December 16,2023
Hopes of new curative treatment for children with neuroblastoma

Hopes of new curative treatment for children with neuroblastoma

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainChildren who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival. However, a group including
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com